Cas no 1248355-05-6 (N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine)

N1-Ethyl-N1-(3-methyl-benzyl)-ethane-1,2-diamine is a specialized diamine compound featuring a branched alkyl and aryl substitution pattern. Its structure, incorporating both ethyl and 3-methyl-benzyl groups on the primary nitrogen, confers unique steric and electronic properties, making it valuable in coordination chemistry and ligand design. The compound’s secondary amine functionality enhances its chelating ability, particularly for transition metal complexes. Its moderate lipophilicity, derived from the aromatic methyl-benzyl moiety, may improve solubility in organic matrices. This diamine is of interest in catalytic applications, polymer modification, and pharmaceutical intermediate synthesis, where tailored amine reactivity and selectivity are required. Handling should adhere to standard safety protocols for amine compounds.
N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine structure
1248355-05-6 structure
Product Name:N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine
CAS No:1248355-05-6
MF:C12H20N2
MW:192.300602912903
CID:2162987
Update Time:2025-06-23

N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine Chemical and Physical Properties

Names and Identifiers

    • N*1*-ethyl-n*1*-(3-methyl-benzyl)-ethane-1,2-diamine
    • AM91300
    • N-Ethyl-N-(3-methylbenzyl)-1,2-ethanediamine
    • N1-ethyl-N1-(3-methylbenzyl)ethane-1,2-diamine
    • N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine
    • Inchi： 1S/C12H20N2/c1-3-14(8-7-13)10-12-6-4-5-11(2)9-12/h4-6,9H,3,7-8,10,13H2,1-2H3
    • InChI Key： DSTVTDMIGUGUSV-UHFFFAOYSA-N
    • SMILES： N(CC)(CCN)CC1C=CC=C(C)C=1

Computed Properties

  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 14
  • Rotatable Bond Count: 5
  • Complexity: 147
  • Topological Polar Surface Area: 29.3

Experimental Properties

  • Density: 1.0±0.1 g/cm3
  • Boiling Point: 266.0±20.0 °C at 760 mmHg
  • Flash Point: 109.0±16.9 °C
  • Vapor Pressure: 0.0±0.5 mmHg at 25°C

N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine Security Information

N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Fluorochem
085879-500mg
N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine
 1248355-05-6
500mg
 ￡320.00 2022-03-01

N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine Related Literature

Additional information on N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine

Introduction to N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine (CAS No. 1248355-05-6)

N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine, identified by its CAS number 1248355-05-6, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This diamine derivative has garnered attention due to its unique structural properties and potential applications in drug development and biochemical research. The compound's molecular structure, featuring an ethyl group and a 3-methyl-benzyl substituent, contributes to its distinctive chemical behavior and reactivity, making it a valuable candidate for further investigation.

The synthesis of N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine involves a series of well-defined chemical reactions that highlight the precision and expertise required in organic synthesis. The process typically begins with the selection of appropriate starting materials, such as ethylene diamine and 3-methylbenzyl chloride, which undergo nucleophilic substitution reactions to form the desired product. This synthetic route underscores the importance of optimizing reaction conditions to achieve high yields and purity, ensuring that the final product meets the stringent requirements of pharmaceutical applications.

In recent years, N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine has been explored for its potential role in the development of novel therapeutic agents. Its diamine core structure suggests utility in the synthesis of polyamine-based drugs, which are known for their broad spectrum of biological activities. Research has indicated that diamines can serve as key intermediates in the creation of compounds with antimicrobial, anti-inflammatory, and anticancer properties. The presence of the 3-methyl-benzyl group further enhances its versatility, allowing for modifications that can fine-tune its pharmacological effects.

One of the most compelling aspects of N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine is its potential application in targeted drug delivery systems. The compound's ability to interact with biological molecules has led to investigations into its use as a carrier molecule for therapeutic agents. By leveraging its structural features, researchers aim to develop formulations that can selectively target specific cells or tissues, thereby improving treatment efficacy while minimizing side effects. This approach aligns with the growing trend toward personalized medicine, where individual patient characteristics are taken into account to optimize therapeutic outcomes.

Advances in computational chemistry have also played a crucial role in understanding the behavior of N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine. Molecular modeling techniques have enabled scientists to predict how this compound interacts with biological targets at the atomic level. These insights have been instrumental in guiding experimental design and optimizing drug candidates for clinical trials. By integrating experimental data with computational predictions, researchers can accelerate the drug discovery process and bring new therapies to market more efficiently.

The safety profile of N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine is another critical consideration in its development as a pharmaceutical agent. Extensive toxicological studies are conducted to assess its potential health risks and ensure that it meets regulatory standards for human use. These studies evaluate various parameters, including acute toxicity, chronic exposure effects, and potential long-term health impacts. The results of these assessments are essential for determining safe dosage levels and identifying any necessary precautions for patients receiving treatments based on this compound.

Future research directions for N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine include exploring its role in emerging therapeutic areas such as neurodegenerative diseases and immunomodulation. The compound's structural features make it a promising candidate for developing drugs that can interact with complex biological pathways involved in these conditions. Additionally, studies are underway to investigate its potential as a scaffold for designing new generations of bioactive molecules with enhanced therapeutic properties.

The interdisciplinary nature of research involving N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine highlights the importance of collaboration between chemists, biologists, pharmacologists, and clinicians. Such partnerships foster innovation and drive progress by combining expertise from different fields to address complex challenges in medicine and healthcare. As our understanding of this compound continues to grow, it is likely that new applications and breakthroughs will emerge, further solidifying its significance in the pharmaceutical industry.

In conclusion, N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine (CAS No. 1248355-05-6) represents a fascinating compound with diverse applications in pharmaceutical chemistry and biochemistry. Its unique structural features and potential biological activities make it a valuable asset in the development of new drugs and therapeutic strategies. As research progresses and our knowledge expands, this compound is poised to play an increasingly important role in addressing some of today's most pressing medical challenges.

1248355-05-6 (N*1*-Ethyl-N*1*-(3-methyl-benzyl)-ethane-1,2-diamine) Related Products

Recommended suppliers
Shanghai Bent Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm